BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia

Infections represent a cause of morbidity and mortality in patients affected by chronic lymphocytic leukemia (CLL). Introduction of new drugs in CLL clinical practice has showed impressive efficacy, in particular those targeting BTK. Among the consistent clinical data, an increasing number of report...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Fiorcari, Stefania, Maffei, Rossana, Vallerini, Daniela, Scarfò, Lydia, Barozzi, Patrizia, Maccaferri, Monica, Potenza, Leonardo, Ghia, Paolo, Luppi, Mario, Marasca, Roberto
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485008/
https://ncbi.nlm.nih.gov/pubmed/32983178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.02158
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados